Fibriclotte(Irccs Policlinico San Donato)

N/A

Report date: 2023/03/28 20:00:38

Base Information

Drug NameFibriclotte(Irccs Policlinico San Donato)
Drug Alias NameN/A
ClassificationBiologics > Blood components
Mechanisms of ActionFibrin modulatorsFibrinogen replacements
TargetsFibrinogen
Therapy Area/IndicationsBlood Loss, SurgicalHemorrhageAfibrinogenemia +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIrccs Policlinico San Donato
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsBlood Loss, SurgicalHemorrhageAfibrinogenemia +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A